Adimab, Inc. Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two Existing Partnerships
LEBANON, N.H.--(BUSINESS WIRE)--Adimab, Inc., a leader in the discovery of fully human antibodies, today announced the initiation of research collaborations with Pfizer and an undisclosed second company. Adimab also announced the receipt of milestone payments from two recently announced discovery collaborations with Merck and Roche.